Eli Lilly Alzheimers Drug Fails Major Test Trial   A drug developed by Eli Lilly to treat patients with Alzheimers disease symptoms failed a closely watched clinical trial. WSJs Jeanne Whalen explains the impact of the failure on Eli Lilly stock and the rest of the pharmaceutical sector which had rested its hopes on the success of the drug. Photo: Kris Tripplaar/Sipa USA

Eli Lilly Alzheimer’s Drug Fails Major Test Trial

Eli Lilly (LLY), a major pharmaceutical company, is perhaps the best example. Not many people found Eli Lilly attractive in late 2010 because its stock wasn’t going up. Ironically, the stock has been on a tear ever since, gaining 159% on a total return basis. As a result, Eli Lilly’s valuation is now sky-high. The following chart shows Eli Lilly’s enterprise value-to-EBITDA multiple and price-to-sales ratio over the past 10 years.

Eli Lilly: Sell This Pharmaceutical Stock Before It Goes Limp

American Stock Market: ELI LILLY AND COMPANY (NYSE) (LLY) BUY !!

American Stock Market: ELI LILLY AND COMPANY (NYSE) (LLY) BUY !!

Eli Lilly offices in New Jersey. The company’s stock has risen 40% in the past...

Putting Eli Lilly’s Biotech Bounce to the Test

Eli Lilly stock FDA approval - CNBC

Eli Lilly shares are cratering after the FDA rejected a $1 billion arthritis drug on safety concerns

Lilly says the FDA needed additional data to "characterize safety concerns across treatment arms" and to determine "the most appropriate doses.

Eli Lilly shares fall on Bernie Sanders tweet - CNBC

Eli Lilly shares fall on Bernie Sanders tweet

Pharma Stocks Plunge After Eli Lilly (LLY) News - YouTube

When you are ready to step up your trading and investing game, enter the InTheMoneyStocks services and get all of the live trades now. The Research Cent.

Major Pharma Short Interest Takes a Small Step Back -- KingstoneInvestmentsGroup.com

The February 12 short interest data have been compared with the previous figures, and for the selected pharmaceutical stocks short interest increased.

Eli Lilly's stock dropped nearly 2 points after Sanders criticized the company's pricing.

Sanders got a rough reception at a private meeting with House Democrats.

Eli Lilly and Co. have announced that their experimental Alzheimer’s treatment has failed to slow mental deterioration in its latest study. Consequently, Lilly shares dropped 11.7 percent on Wednesday.

Eli Lilly and Co. have announced that their experimental Alzheimer’s treatment has failed to slow mental deterioration in its latest study. Consequently, Lilly shares dropped percent on Wednesday.

New diabetes guidelines imminent, Jardiance sales may surge

New diabetes guidelines imminent, Jardiance sales may surge

A screen displays trading information for stocks; Pfizer, Abbott Laboratories, Merck and Company and Eli Lilly and Company on the floor of the New York Stock Exchange (NYSE) in New York City, U., May REUTERS/Brendan McDermid/File Photo

Cramer: Dumping Eli Lilly is a huge mistake http://amapnow.com http://my.gear.host.com http://needava.com http://renekamstra.com

Cramer: Dumping this stock is a huge mistake

Eli Lilly’s revenue has actually declined over the past five years, in large part due to expiring patents. Operating profit has shrunk from $6.5 billion all the way down to $2.3 billion.  Meanwhile, Eli Lilly’s profit margin has been cut nearly in half. It’ll be very challenging to return margins to their prior levels for a variety of reasons. For example, the patent on Cialis, a high-margin erectile dysfunction drug, expires in 2017.

Eli Lilly: Sell This Pharmaceutical Stock Before It Goes Limp

Point Roberts WA, New York, NY - February 19, 2014 (Investorideas.com Biotech Newswire) Investorideas.com global news source covering leading sectors including biotech and pharma reports on companies in the sector targeting pancreatic cancer. Stocks mentioned include NewLink Genetics (NLNK), Sunshine Biopharma Inc. ( OTCBB: SBFM ), Eli Lilly and Company (NYSE:LLY) and Celgene (NASDAQ:CELG).

Point Roberts WA, New York, NY - February 19, 2014 (Investorideas.com Biotech Newswire) Investorideas.com global news source covering leading sectors including biotech and pharma reports on companies in the sector targeting pancreatic cancer. Stocks mentioned include NewLink Genetics (NLNK), Sunshine Biopharma Inc. ( OTCBB: SBFM ), Eli Lilly and Company (NYSE:LLY) and Celgene (NASDAQ:CELG).

StockConsultant.com - $LLY (LLY) Eli Lilly stock flat top breakout, analysis chart

StockConsultant.com - $LLY (LLY) Eli Lilly stock flat top breakout, analysis chart

Glaxo Slides After Bernie Sanders Tweets Company "Put Patients At Risk To Increase Profits"  Yesterday, Bernie Sanders slammed Eli Lilly stock after the former presidential candidate and Vermont Senator asked "why has the price of Humalog insulin gone up 700% in 20 years? It's simple. The drug industry's greed", sending LLY stock to 7 month lows.

"The business model of the drug industry is fraud. Glaxo put patients at risk to increase their profits.

Pinterest
Search